NHS England and continence - at last, the potential for some real improvements
NHS England has embarked on a programme called 'Excellence in continence care,' to ensure that commissioners invest in continence services. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 28, 2015 Category: Neurology Source Type: news
Personal Independent Payments (PIP)
As the Benefits Minister is due to appear before the public accounts committee, an article looks at the problems with PIP, both running the systems and the human effect of delays, assessments and reapplications. Includes a case study of a woman with MS.
Guardian
Benefits - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 27, 2015 Category: Neurology Source Type: news
Join the Big Blue Jump this MS Awareness Week!
Do something amazing this MS Awareness Week - take on a thrilling skydive and experience the incredible, once in a life time feeling of freefalling 10,000 feet at 120mph! (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 22, 2015 Category: Neurology Source Type: news
Beta interferon and Copaxone relapse rates similar
A study has found that over 10 years the relapse rate for people on glatiramer acetate or beta interferon is similar.
MS Discovery Forum
Disease modifying drugs for relapsing remitting MS - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 20, 2015 Category: Neurology Source Type: news
Progressive MS research
The February 2015 issue of Lancet Neurology contains a series of articles by MS researchers on current research activity into progressive MS.
National MS Society (USA)
Progressive MS - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 20, 2015 Category: Neurology Source Type: news
Stomach bacteria might protect against MS
A study in Australia suggests that women infected with the common stomach bug Helicobacter pylori (H.pylori) have a lower risk of developing multiple sclerosis. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 20, 2015 Category: Neurology Source Type: news
HIV and MS
British research shows that people with HIV have a very low risk of developing MS. A trial is underway to see if an antiretroviral drug used in HIV is effective in MS.
MSIF
Getting involved in research (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 19, 2015 Category: Neurology Source Type: news
Corpus callosum associated with cognitive symptoms
A study that followed 37 people with MS over 17 years has found that damage to an area of the brain called the corpus callosum is highly associated cognitive symptoms and moderately associated with physical disability.
MS Discovery Forum
Cognitive symptoms - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 16, 2015 Category: Neurology Source Type: news
Wheelchair assessments
A study at Brunel University has highlighted the need for a proper assessment of people needing a wheelchair in order to identify and manage health issues other than just mobility.
Brunel University
Wheelchair services - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 15, 2015 Category: Neurology Source Type: news
Physiotherapy iniative in Bristol
How the a programme run by the BRAMS centre in Bristol is helping people with MS improve their mobility and balance.
Bristol Post
Physiotherapy - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 15, 2015 Category: Neurology Source Type: news
MS patients are 'invisible' in most Clinical Commissioning Groups (CCGs)
The Invisible Patients, a new report published today by the Neurological Alliance has found that people with MS in England are unknown to their local Clinical Commissioning Groups. The Neurological Alliance sent Freedom of Information requests to all CCGs, to ascertain how aware they are of neurological conditions in their patch. What they found was: (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 14, 2015 Category: Neurology Source Type: news
Stem cell 'trial' questioned
Canadians who have paid up to $45,000 for treatment in India as part of what was billed as a trial have started questioning the 'doctor' who ran the scheme.
Winnipeg Free Press
Stem cells: the hope and the hype - Open Door article (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 13, 2015 Category: Neurology Source Type: news
Plegridy approved in Scotland
The SMC has approved Plegridy, a version of beta interferon taken less frequently, for the NHS in Scotland.
Pharma Times
Peginterferon beta-1a (Plegridy) - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 13, 2015 Category: Neurology Source Type: news
John Shuttleworth to perform in aid of MS
John Shuttleworth and friends (including Chas and Dave, Toyah, Martyn Ware, John Otway, Gordon Giltrap and others to be announced) will perform for one night only at the London Palladium in 'A Knight at the Palladium' in aid of the MS Trust and an MS Centre in Sheffield. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 13, 2015 Category: Neurology Source Type: news
Plegridy will be available on the NHS in Scotland
The Scottish Medicines Consortium (SMC) has approved peginterferon beta-1a (Plegridy) as a treatment for relapsing remitting multiple sclerosis on the NHS in Scotland. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - January 13, 2015 Category: Neurology Source Type: news
